Kestra Medical Technologies, Ltd. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Kestra Medical Technologies, Ltd. | KMTS - NASDAQ |
$14.00-$16.00 | $17.00 | $22.95 | 11.9 million | 3/6/2025 |
| BofA Securities, Goldman Sachs, Piper Sandler, Wells Fargo, Stifel | ||||||
Co-Manager(s): Wolfe | Nomura Alliance | ||||||
| Health Care | ||||||
Filing(s): Filed 2025-02-10 Terms Added 2025-02-26 | ||||||
Kestra Medical Technologies, Ltd. Quote & Chart - Click for current quote - KMTS
IPO Boutique aggregates information on public companies and private companies, such as "KMTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Kestra Medical Technologies, Ltd. (adapted from Kestra Medical Technologies, Ltd. prospectus):
They are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "KMTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.